Logo image
The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning
Journal article   Open access   Peer reviewed

The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning

Robert F Mullins, Desi P Schoo, Elliott H Sohn, Miles J Flamme-Wiese, Grefachew Workamelahu, Rebecca M Johnston, Kai Wang, Budd A Tucker and Edwin M Stone
The American journal of pathology, Vol.184(11), pp.3142-3153
11/2014
DOI: 10.1016/j.ajpath.2014.07.017
PMCID: PMC4215023
PMID: 25204844
url
https://doi.org/10.1016/j.ajpath.2014.07.017View
Published (Version of record) Open Access

Abstract

Age-related macular degeneration (AMD) is a common disease that can result in severe visual impairment. Abnormal regulation of the complement system has been implicated in its pathogenesis, and CFH polymorphisms contribute substantially to risk. How these polymorphisms exert their effects is poorly understood. We performed enzyme-linked immunosorbent assay (ELISA) analysis on young, aged, and AMD choroids to determine the abundance of the membrane attack complex (MAC) and performed immunofluorescence studies on eyes from 117 donors to evaluate the MAC in aging, early AMD, and advanced AMD. Morphometric studies were performed on eyes with high- or low-risk CFH genotypes. ELISA confirmed that MAC increases significantly with aging and with AMD. MAC was localized to Bruch's membrane and the choriocapillaris and was detectable at low levels as early as 5 years of age. Hard drusen were labeled with anti-MAC antibody, but large or confluent drusen and basal deposits were generally unlabeled. Labeling of retinal pigment epithelium was observed in some cases of advanced AMD, but not in early disease. Eyes homozygous for the high-risk CFH genotype had thinner choroids than low-risk homozygotes (P < 0.05). These findings suggest that increased complement activation in AMD and in high-risk genotypes can lead to loss of endothelial cells in early AMD. Treatments to protect the choriocapillaris in early AMD are needed.
Retinal Pigment Epithelium - metabolism Complement Membrane Attack Complex - metabolism Humans Middle Aged Child, Preschool Infant Male Complement Membrane Attack Complex - genetics Young Adult Retinal Pigment Epithelium - pathology Aging - genetics Aged, 80 and over Adult Female Choroid - pathology Infant, Newborn Choroid - metabolism Aging - pathology Macular Degeneration - metabolism Complement Factor H - metabolism Macular Degeneration - genetics Aged Complement Factor H - genetics Aging - metabolism Macular Degeneration - pathology

Details

Logo image